You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 131 No. 10, October 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correction
 This Article
 •PDF of this Correction
 •Original article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Error in Figure in: A Replication-Selective Adenoviral Vector for Head and Neck Cancers

Arch Otolaryngol Head Neck Surg. 2005;131:920.

In the Original Article by Tanaka et al titled "A Replication-Selective Adenoviral Vector for Head and Neck Cancers," published in the July issue of the ARCHIVES (2005;131:630-634), an error occurred on page 633 in Figure 3B. In that figure, the lines connecting the data points were inadvertently omitted. The entire correct Figure 3 is reprinted here with its legend. The journal regrets the error.



View larger version (19K):
[in this window]
[in a new window]
Figure 3. Inhibition of human head and neck squamous cell carcinoma and 293 cell lines in vitro. Ad-COX2-E1a significantly inhibited cancer cell growth (A), whereas Ad-CMV-{beta}gal did not affect the cell growth of head and neck squamous cell carcinoma cell lines (B). The survival rates were calculated on the assumption that the rate of noninfected cells was 100%. Each point represents triplicate averages with standard deviation bars. MOI indicates multiplicities of infection.








HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.